Switch theme
Sign up to access all valuation multiples
BIO-UV Group is a manufacturer of ultraviolet (UV) water treatment equipment in France. It designs, manufactures and markets systems and concepts of disinfection by ultraviolet light (UV-C) adapted to the number of applications. The company offers products for disinfecting swimming pools and private and collective hot tubs, treating wastewater, producing drinking water, treating bilge water from ships and water from aquariums.
2000
61
LTM Revenue $47.5M
LTM EBITDA $6.4M
$55.2M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
BIO-UV has a last 12-month revenue (LTM) of $47.5M and a last 12-month EBITDA of $6.4M.
In the most recent fiscal year, BIO-UV achieved revenue of $46.6M and an EBITDA of $4.9M.
BIO-UV expects next 12-month revenue of XXX and NTM EBITDA of XXX
See BIO-UV valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $47.5M | XXX | $46.6M | XXX | XXX | XXX |
| Gross Profit | n/a | XXX | $28.4M | XXX | XXX | XXX |
| Gross Margin | n/a | XXX | 61% | XXX | XXX | XXX |
| EBITDA | $6.4M | XXX | $4.9M | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 11% | XXX | XXX | XXX |
| EBIT | $2.7M | XXX | $2.5M | XXX | XXX | XXX |
| EBIT Margin | 6% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | $0.7M | XXX | $37K | XXX | XXX | XXX |
| Net Margin | 2% | XXX | 0% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $20.1M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 11, 2025, BIO-UV's stock price is EUR 2 (or $2).
BIO-UV has current market cap of EUR 26.7M (or $31.5M), and EV of EUR 46.8M (or $55.2M).
See BIO-UV trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $55.2M | $31.5M | XXX | XXX | XXX | XXX | $0.06 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 11, 2025, BIO-UV has market cap of $31.5M and EV of $55.2M.
BIO-UV's trades at 1.2x EV/Revenue multiple, and 11.2x EV/EBITDA.
Equity research analysts estimate BIO-UV's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
BIO-UV has a P/E ratio of 42.3x.
See valuation multiples for BIO-UV and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $31.5M | XXX | $31.5M | XXX | XXX | XXX |
| EV (current) | $55.2M | XXX | $55.2M | XXX | XXX | XXX |
| EV/Revenue | 1.2x | XXX | 1.2x | XXX | XXX | XXX |
| EV/EBITDA | 8.6x | XXX | 11.2x | XXX | XXX | XXX |
| EV/EBIT | 20.3x | XXX | 22.0x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | 42.3x | XXX | 851.9x | XXX | XXX | XXX |
| EV/FCF | 10.5x | XXX | 9.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialBIO-UV's last 12 month revenue growth is 4%
BIO-UV's revenue per employee in the last FY averaged $0.8M, while opex per employee averaged $0.4M for the same period.
BIO-UV's rule of 40 is 17% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
BIO-UV's rule of X is 24% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for BIO-UV and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Growth | 5% | XXX | 2% | XXX | XXX | XXX |
| Rule of 40 | 17% | XXX | 15% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 24% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.8M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 55% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| XXX | XXX | XXX | XXX | XXX | XXX | |
| Aalberts | XXX | XXX | XXX | XXX | XXX | XXX |
| Doppler | XXX | XXX | XXX | XXX | XXX | XXX |
| Frigoglass | XXX | XXX | XXX | XXX | XXX | XXX |
| Petros Petropoulos | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
BIO-UV acquired XXX companies to date.
Last acquisition by BIO-UV was XXXXXXXX, XXXXX XXXXX XXXXXX . BIO-UV acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was BIO-UV founded? | BIO-UV was founded in 2000. |
| Where is BIO-UV headquartered? | BIO-UV is headquartered in France. |
| How many employees does BIO-UV have? | As of today, BIO-UV has 61 employees. |
| Is BIO-UV publicy listed? | Yes, BIO-UV is a public company listed on PAR. |
| What is the stock symbol of BIO-UV? | BIO-UV trades under ALTUV ticker. |
| When did BIO-UV go public? | BIO-UV went public in 2018. |
| Who are competitors of BIO-UV? | Similar companies to BIO-UV include e.g. , Aalberts, Doppler, Frigoglass. |
| What is the current market cap of BIO-UV? | BIO-UV's current market cap is $31.5M |
| What is the current revenue of BIO-UV? | BIO-UV's last 12 months revenue is $47.5M. |
| What is the current revenue growth of BIO-UV? | BIO-UV revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of BIO-UV? | Current revenue multiple of BIO-UV is 1.2x. |
| Is BIO-UV profitable? | Yes, BIO-UV is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of BIO-UV? | BIO-UV's last 12 months EBITDA is $6.4M. |
| What is BIO-UV's EBITDA margin? | BIO-UV's last 12 months EBITDA margin is 14%. |
| What is the current EV/EBITDA multiple of BIO-UV? | Current EBITDA multiple of BIO-UV is 8.6x. |
| What is the current FCF of BIO-UV? | BIO-UV's last 12 months FCF is $5.3M. |
| What is BIO-UV's FCF margin? | BIO-UV's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of BIO-UV? | Current FCF multiple of BIO-UV is 10.5x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
